Home > Insider Trading > Filing (0001104659-22-088033)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1739426	Rvl Pharmaceuticals Plc	RVLP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1374179	F David Burgstahler	C/O Avista Capital Partners Iii, 65 East 55Th Street, 18Th Floor New York NY 10022		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2022-08-08	8,000,000	$1.55	23,730,864	No	4	P	Indirect	By Avista Capital investment fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Avista Capital investment fund

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	1,032,995	Indirect	By Avista Capital investment fund

Footnotes

Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. Mr. Burgstahler is a member of the investment committee of AHP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by AHP. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
Represents shares of the Issuer held by Orbit Co-Invest III LLC. Avista Capital Partners III GP, L.P. ("ACP GP") is the manager of Orbit Co-Invest III LLC. Mr. Burgstahler is a member of the investment committee of ACP GP. By virtue of this relationship, Mr. Burgstahler may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Mr. Burgstahler disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.